ANPATH GROUP, INC. ANNOUNCES NEW DISTRIBUTION PARTNER IN
For Release: Immediate
The Company announced that
“We are very pleased to add this quality partner, one with such a sterling reputation in the large and growing Korean market, to our team. This move is the continuation of our initial strategic plan to expand our product offering into worldwide markets of opportunity”, stated J.
Mr. Breedlove continued, “The economy of South Korea is the third largest in Asia and the twelfth largest in the world in terms of nominal GDP as of 2006. From the mid to late twentieth century, it has enjoyed one of the fastest rates of prolonged economic growth in history. Clebio was established in 2003 and has enjoyed similar fast growth through the leadership and experience of Mr. Cho. The company currently has two offices, 15 direct employees and an extensive sub-representative/distributor network throughout the country.” Dexter Cho, President of Clebio stated, “We are excited about this opportunity and expect to be very successful. Clebio, with the support of
Anpath Group, Inc., through its wholly-owned subsidiary EnviroSystems, Inc., produces cleaning and disinfecting products that will help prevent the spread of infectious microorganisms while minimizing the harmful effects to people, equipment or the environment. EnviroSystems, Inc. is focused on safe infection prevention technologies that are expected to position the company in the forefront of the industry at a time when there is rapidly growing awareness of the critical need to prevent biological risks — both natural and man-made. This release contains forward-looking statements, which reflect expectation or belief by Anpath Group concerning future events that involve risks and uncertainties. Anpath Group can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Anpath Group expectations, including, but not limited to EPA registration of the Company’s products, the Company’s ability to carry out its business plan, successful development and commercial acceptance of its products, ability to fund development of its technology, the risk that products may not result from development activities, protection of its intellectual property, need for regulatory approvals, and other factors discussed in periodic Anpath Group filings with the Securities and Exchange Commission. Forward-looking statements are qualified in their entirety by the above cautionary statement. Anpath Group assumes no duty to update its outlook or other forward-looking statements as of any future date. J. Lloyd Breedlove
|